146 related articles for article (PubMed ID: 36727012)
1. Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy.
Zhu Y; Ye L; Huang H; Xu X; Liu Y; Wang J; Jin Y
Front Pediatr; 2022; 10():1042302. PubMed ID: 36727012
[TBL] [Abstract][Full Text] [Related]
2. Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
Alazami AM; Al-Helale M; Alhissi S; Al-Saud B; Alajlan H; Monies D; Shah Z; Abouelhoda M; Arnaout R; Al-Dhekri H; Al-Numair NS; Ghebeh H; Sheikh F; Al-Mousa H
Front Immunol; 2018; 9():203. PubMed ID: 29479355
[TBL] [Abstract][Full Text] [Related]
3. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
Shamriz O; Simon AJ; Lev A; Megged O; Ledder O; Picard E; Joseph L; Molho-Pessach V; Tal Y; Millman P; Slae M; Somech R; Toker O; Berger M
Clin Exp Immunol; 2020 Jun; 200(3):215-227. PubMed ID: 32201938
[TBL] [Abstract][Full Text] [Related]
4. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
Kolukisa B; Baser D; Akcam B; Danielson J; Bilgic Eltan S; Haliloglu Y; Sefer AP; Babayeva R; Akgun G; Charbonnier LM; Schmitz-Abe K; Kendir Demirkol Y; Zhang Y; Gonzaga-Jauregui C; Jimenez Heredia R; Kasap N; Kiykim A; Ozek Yucel E; Gok V; Unal E; Pac Kisaarslan A; Nepesov S; Baysoy G; Onal Z; Yesil G; Celkan TT; Cokugras H; Camcioglu Y; Eken A; Boztug K; Lo B; Karakoc-Aydiner E; Su HC; Ozen A; Chatila TA; Baris S
Allergy; 2022 Mar; 77(3):1004-1019. PubMed ID: 34287962
[TBL] [Abstract][Full Text] [Related]
5. A Novel Pathogenic Variant in
Yonkof JR; Gupta A; Rueda CM; Mangray S; Prince BT; Rangarajan HG; Alshahrani M; Varga E; Cripe TP; Abraham RS
Front Immunol; 2020; 11():884. PubMed ID: 32625199
[TBL] [Abstract][Full Text] [Related]
6. A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.
Kurolap A; Eshach Adiv O; Konnikova L; Werner L; Gonzaga-Jauregui C; Steinberg M; Mitsialis V; Mory A; Nunberg MY; Wall S; Shaoul R; Overton JD; ; Shuldiner AR; Zohar Y; Paperna T; Snapper SB; Shouval DS; Baris Feldman H
J Clin Immunol; 2019 May; 39(4):430-439. PubMed ID: 31079270
[TBL] [Abstract][Full Text] [Related]
7. CARMIL2 is a novel molecular connection between vimentin and actin essential for cell migration and invadopodia formation.
Lanier MH; Kim T; Cooper JA
Mol Biol Cell; 2015 Dec; 26(25):4577-88. PubMed ID: 26466680
[TBL] [Abstract][Full Text] [Related]
8. A potential founder variant in
Sorte HS; Osnes LT; Fevang B; Aukrust P; Erichsen HC; Backe PH; Abrahamsen TG; Kittang OB; Øverland T; Jhangiani SN; Muzny DM; Vigeland MD; Samarakoon P; Gambin T; Akdemir ZH; Gibbs RA; Rødningen OK; Lyle R; Lupski JR; Stray-Pedersen A
Mol Genet Genomic Med; 2016 Nov; 4(6):604-616. PubMed ID: 27896283
[TBL] [Abstract][Full Text] [Related]
9. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
Lévy R; Gothe F; Momenilandi M; Magg T; Materna M; Peters P; Raedler J; Philippot Q; Rack-Hoch AL; Langlais D; Bourgey M; Lanz AL; Ogishi M; Rosain J; Martin E; Latour S; Vladikine N; Distefano M; Khan T; Rapaport F; Schulz MS; Holzer U; Fasth A; Sogkas G; Speckmann C; Troilo A; Bigley V; Roppelt A; Dinur-Schejter Y; Toker O; Bronken Martinsen KH; Sherkat R; Somekh I; Somech R; Shouval DS; Kühl JS; Ip W; McDermott EM; Cliffe L; Ozen A; Baris S; Rangarajan HG; Jouanguy E; Puel A; Bustamante J; Alyanakian MA; Fusaro M; Wang Y; Kong XF; Cobat A; Boutboul D; Castelle M; Aguilar C; Hermine O; Cheminant M; Suarez F; Yildiran A; Bousfiha A; Al-Mousa H; Alsohime F; Cagdas D; Abraham RS; Knutsen AP; Fevang B; Bhattad S; Kiykim A; Erman B; Arikoglu T; Unal E; Kumar A; Geier CB; Baumann U; Neven B; ; Rohlfs M; Walz C; Abel L; Malissen B; Marr N; Klein C; Casanova JL; Hauck F; Béziat V
J Exp Med; 2023 Feb; 220(2):. PubMed ID: 36515678
[TBL] [Abstract][Full Text] [Related]
10. A human immunodeficiency syndrome caused by mutations in CARMIL2.
Schober T; Magg T; Laschinger M; Rohlfs M; Linhares ND; Puchalka J; Weisser T; Fehlner K; Mautner J; Walz C; Hussein K; Jaeger G; Kammer B; Schmid I; Bahia M; Pena SD; Behrends U; Belohradsky BH; Klein C; Hauck F
Nat Commun; 2017 Jan; 8():14209. PubMed ID: 28112205
[TBL] [Abstract][Full Text] [Related]
11. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report.
Zamani R; Zoghi S; Shahkarami S; Seyedpour S; Jimenez Heredia R; Boztug K; Rezaei N
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):596-605. PubMed ID: 37855284
[TBL] [Abstract][Full Text] [Related]
12. A Novel
Coffey EL; Ma L; Cissé OH; Kovacs JA; Minor KM; Sukura A; Danesi P; Friedenberg SG; Cullen JN; Weissenbacher-Lang C; Nadeau JC; Graham AM; Granick MN; Branson NK; Branson KC; Blasi B; Jacobs CM; Furrow E
J Fungi (Basel); 2024 Mar; 10(3):. PubMed ID: 38535207
[TBL] [Abstract][Full Text] [Related]
13. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
Magg T; Shcherbina A; Arslan D; Desai MM; Wall S; Mitsialis V; Conca R; Unal E; Karacabey N; Mukhina A; Rodina Y; Taur PD; Illig D; Marquardt B; Hollizeck S; Jeske T; Gothe F; Schober T; Rohlfs M; Koletzko S; Lurz E; Muise AM; Snapper SB; Hauck F; Klein C; Kotlarz D
Inflamm Bowel Dis; 2019 Oct; 25(11):1788-1795. PubMed ID: 31115454
[TBL] [Abstract][Full Text] [Related]
14. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
Bosa L; Batura V; Colavito D; Fiedler K; Gaio P; Guo C; Li Q; Marzollo A; Mescoli C; Nambu R; Pan J; Perilongo G; Warner N; Zhang S; Kotlarz D; Klein C; Snapper SB; Walters TD; Leon A; Griffiths AM; Cananzi M; Muise AM
Sci Rep; 2021 Mar; 11(1):5945. PubMed ID: 33723309
[TBL] [Abstract][Full Text] [Related]
15. CARMIL2 Immunodeficiency with Epstein Barr Virus Associated Smooth Muscle Tumor (EBV-SMT). Report of a Case with Comprehensive Review of Literature.
Vij M; Sivasankaran M; Jayaraman D; Sankaranarayanan S; Kumar V; Munirathnam D; Scott J
Fetal Pediatr Pathol; 2022 Dec; 41(6):1023-1034. PubMed ID: 34738861
[No Abstract] [Full Text] [Related]
16. [X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia: report of a family and literature review].
He TY; Xia Y; Li CG; Li CR; Qi ZX; Yang J
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):48-52. PubMed ID: 29342998
[No Abstract] [Full Text] [Related]
17. [De novo NFκB2 gene mutation associated common variable immunodeficiency].
Luo MZ; Xu T; Xue XH; Wang YP; Wu PL; Chen XM; Tang XM; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):628-632. PubMed ID: 30078247
[No Abstract] [Full Text] [Related]
18. Partial T cell defects and expanded CD56
Cifaldi C; Cotugno N; Di Cesare S; Giliani S; Di Matteo G; Amodio D; Piano Mortari E; Chiriaco M; Buonsenso D; Zangari P; Pagliara D; Gaspari S; Carsetti R; Palma P; Finocchi A; Locatelli F; Rossi P; Doria M; Cancrini C
J Leukoc Biol; 2020 Aug; 108(2):739-748. PubMed ID: 32392633
[TBL] [Abstract][Full Text] [Related]
19. An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome.
Costa-Carvalho BT; Viana MA; Brunialti MK; Kallas EG; Salomao R
Clin Exp Immunol; 2004 May; 136(2):291-6. PubMed ID: 15086393
[TBL] [Abstract][Full Text] [Related]
20. Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1.
Cui Y; Keles S; Charbonnier LM; Julé AM; Henderson L; Celik SC; Reisli I; Shen C; Xie WJ; Schmitz-Abe K; Wu H; Chatila TA
J Allergy Clin Immunol; 2020 Jan; 145(1):391-401.e8. PubMed ID: 31629014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
